首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of new hexahydro- and octahydropyrido(1,2-c)pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
【24h】

Synthesis of new hexahydro- and octahydropyrido(1,2-c)pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.

机译:合成具有芳基哌嗪部分作为5-HT1A和5-HT2A受体配体的六氢-和八氢吡啶并(1,2-c)嘧啶衍生物。第4部分

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

New 4-aryl-2H-pyrido[1,2-c]pyrimidine-1,3-dione derivatives of arylpiperazine (6-18) were prepared and evaluated in vitro for their affinity for 5-HT1A, 5-HT2A, and alpha1 receptors. The influence of ortho substitution in the phenyl ring, substitution at position 4 of the pyrido[1,2-c]pyrimidine system, and its unsaturation degree were explored. The tested compounds showed high affinity for the 5-HT1A receptor (Ki = 1.3-79.2 nM) and moderate to low affinity for the 5-HT2A (Ki = 51.7-1405 nM) and alpha1 receptors (Ki = 19.7-382.3 nM). Compounds 8 and 10 showed the highest 5-HT1A receptor affinity (Ki = 1.3 and 2.2 nM, respectively) and were 37- and 35.9-fold, respectively, more selective in relation to alpha1 adrenoreceptors.
机译:制备了芳基哌嗪(6-18)的新的4-芳基-2H-吡啶基[1,2-c]嘧啶-1,3-二酮衍生物,并对其在体外对5-HT1A,5-HT2A和α1的亲和力进行了评估。受体。探索了邻位取代在苯环,吡啶并[1,2-c]嘧啶体系第4位的取代及其不饱和度的影响。所测试的化合物显示出对5-HT1A受体的高亲和力(Ki = 1.3-79.2 nM),对5-HT2A(Ki = 51.7-1405 nM)和alpha1受体(Ki = 19.7-382.3 nM)具有中等至低亲和力。化合物8和10显示出最高的5-HT1A受体亲和力(分别为Ki = 1.3和2.2 nM),分别是37倍和35.9倍,相对于α1肾上腺素受体更具选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号